Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

J M Smucker Co (SJM) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Global neonatal infant care market to reach $5.59B by 2035 with 6.21% CAGR driven by rising preterm births.

The global neonatal infant care market, valued at $3.06 billion in 2025, is projected to grow to $5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by increasing preterm births and neonatal complications like respiratory disorders and jaundic...

Market News
2 hours ago
Custom Market Insights
Neutral
pluang ai news

FDA approves Casgevy gene therapy for children 2+ with sickle cell disease and beta thalassemia

The FDA has approved Casgevy, a gene therapy using CRISPR technology, for children aged 2 and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). This therapy modifies patients' own stem cells to increase fetal hemo...

Market News
3 hours ago
U.S. Food And Drug Administration
Neutral
pluang ai news

Ribo and Madrigal reach key milestone in siRNA drug development for liver disease MASH

Suzhou Ribo Life Science and Madrigal Pharmaceuticals have achieved the first candidate drug nomination milestone in their siRNA partnership targeting metabolic dysfunction-associated steatohepatitis (MASH). This milestone marks progress toward clini...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
pluang ai news

Ant Group leads $73.58M funding round in humanoid robot startup Zeroth amid AI push

Ant Group has led a $73.58 million funding round in Zeroth, a humanoid robotics startup, marking its 12th investment in the sector since early 2025. Zeroth focuses on robots for elderly care, pet care, and children's education, with plans to expand s...

Market News
4 hours ago
CNBC
Bullish
news icon
pluang ai news

Abbisko and AstraZeneca partner to develop new lung cancer combo therapy, cleared for Phase I/II trials in China.

Abbisko Therapeutics and AstraZeneca have formed a strategic collaboration to advance a novel combination therapy for non-small cell lung cancer (NSCLC) involving Abbisko's oral PD-L1 inhibitor lumipodlin and AstraZeneca's EGFR-TKI Tagrisso. The Phas...

Market News
4 hours ago
PRNewsWire
Bullish
news icon
pluang ai news

Oil prices drop as US-Iran talks in Qatar show progress, easing Middle East supply fears

Oil prices fell after indirect negotiations between the US and Iran in Qatar showed positive progress. US President Donald Trump said talks on Iran's denuclearization were going well, easing investor concerns about Middle East oil supply disruptions....

Market News
4 hours ago
CNBC
Neutral
pluang ai news

AI/R Avenue Code earns Google Gemini Enterprise competency, boosting secure AI adoption in businesses.

AI/R Avenue Code, a subsidiary of AI/R, has achieved Google's Gemini Enterprise competency, recognizing its expertise in deploying advanced AI solutions securely in enterprises. This certification highlights their strengths in security, workflow auto...

Market News
5 hours ago
Not Specified
Bullish
news icon
pluang ai news

Alibaba to pay $600M for failing to stop illegal sales on its U.S. platforms

Alibaba and its U.S. payment processor AUS Merchant Services will pay a total of $600 million to the U.S. Department of Justice after admitting they failed to prevent tens of thousands of illegal product sales, including pharmaceuticals and controlle...

Market News
5 hours ago
Fox Business
Bearish
news icon
pluang ai news

Copart CEO steps down amid securities fraud probe, shares drop 8%

Copart announced that CEO Jeff Liaw will step down on July 31, 2026, coinciding with an investigation by Pomerantz LLP into possible securities fraud and unlawful practices involving the company and its officers. Following the announcement, Copart's ...

Market News
5 hours ago
PRNewsWire
Bearish
news icon
pluang ai news

Larimar Therapeutics faces investigation over safety concerns in drug trials causing stock drops

Larimar Therapeutics is under investigation by Pomerantz LLP for potential securities fraud related to safety issues in its drug trials for nomlabofusp, a treatment for Friedreich's Ataxia. Despite positive data claims, reports of severe allergic rea...

Market News
5 hours ago
PRNewsWire
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • MARKET_CAP
    $12.02B
  • VOLUME
    -
  • SECTOR
    Consumer Staples
  • FIFTY_TWO_WEEK_HIGH
    $117.05
  • FIFTY_TWO_WEEK_LOW
    $89.53
  • TYPICAL_HOLD_TIME
    -
  • ENTERPRISE_VALUE
    $19.05B
  • DIVIDEND_YIELD
    3.91%
  • TRADING_ACTIVITY
    -
$114.8
52W Low: $89.53
13 Apr 2026
52W High: $117.05
10 Jun 2026

Track J M Smucker Co (SJM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, J M Smucker Co has traded between a low of $89.53 and a high of $117.05, highlighting its annual price range. Buy and sell J M Smucker Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!